Skip to main content
SpringerLink
Log in

Quinaprilat-Induced Vasodilatation in Forearm Vasculature of Patients with Essential Hypertension: Comparison with Enalaprilat

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

The aim of the present study was to assess the possible differences in hemodynamic and neurohumoral responses to local ACE inhibition in the human forearm of patients with essential hypertension with either quinaprilat or enalaprilat. Forearm vascular responses to infusion of quinaprilat or enalaprilat (0.5 μg/dL/min) into the brachial artery were studied in 12 male patients with essential hypertension. The experiments were performed in a randomized, double-blind, crossover fashion. Before and during ACE inhibition, the vasoconstrictor response to four cumulative doses of angiotensin I (Ang I) was studied. Forearm blood flow was assessed using venous occlusion plethysmography. Local quinaprilat infusion induced a more rapid (even after 15 minutes; median vasodilation quinaprilat 29% vs. enalaprilat −1%, P > 0.02) and longer lasting forearm vaso-dilation as compared with enalaprilat. After 15 minutes of local ACE inhibition, the vasoconstrictor response to Ang I was completely blocked by both ACE inhibitors. We conclude that in patients with essential hypertension quinaprilat induces a more rapid and longer lasting vasodilatation than enalaprilat. These effects of quinaprilat are possibly related to its higher affinity for vascular ACE. On the other hand, the fact that these effects of quinaprilat were observed despite a similar degree of ACE inhibition as during enalaprilat may suggest that quinaprilat directly stimulates another vasodilatating mechanism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ferrari R, Ceconi C, Curello S, Pepi P, Mazzoletti A, Visioli O. Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease. Cardiovasc Drugs Ther 1996;10 (Suppl. 2):639-647.

    PubMed  Google Scholar 

  2. Sakaguchi K, Chai SY, Jackson B, Johnston CI, Mendelsohn FA. Inhibition of tissue angiotensin converting enzyme: Quantitation by autoradiography. Hypertension 1988;11:230-238.

    PubMed  Google Scholar 

  3. Unger T, Ganten D, Lang RE, Scholkens BA. Persistent tissue converting enzyme inhibition following chronic treatment with Hoe 98 and MK421 in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1985;7:36-41.

    PubMed  Google Scholar 

  4. Cohen ML, Kurz KD. Angiotensin converting enzyme inhibition in tissue from spontaneously hypertensive rats after treatment with captopril of MK421. J Pharmacol Exp Ther 1982;220:63-69.

    PubMed  Google Scholar 

  5. Brunner MR, Gavras M, Waeber B. Oral angiotensin converting enzyme inhibitors in longterm treatment of hypertensive patients. Ann Intern Med 1979;90:19-23.

    PubMed  Google Scholar 

  6. Karlberg BE, Asplund J, Wettre S, Ohman KP. Longterm experience of captopril in the treatment of primary (essential) hypertension. Br J Clin Pharmacol 1982;14:133S-137S.

    PubMed  Google Scholar 

  7. Fabris B, Jackson B, Cubela R, Mendelsohn FAO, Johnson CI. Angiotensin converting enzyme in the rat heart: Studies of its inhibition in vitro and ex vitro. Clin Exp Pharmacol Physiol 1989;16:309-313.

    PubMed  Google Scholar 

  8. Oosterga M, Voors AA, Buikema H, et al. Angiotensin II formation in human vasculature after chronic ACE inhibition: A prospective, randomized, placebo-controlled study. QUO VADIS Investigators. Cardiovasc Drugs Ther 2000;14:55-60.

    PubMed  Google Scholar 

  9. Johnston CI, Fabris B, Yamada H, et al. Comparative studies of tissue inhibition by angiotensin-converting enzyme inhibition. J Hyperten 1989;7(Suppl. 5):S11-S16.

    Google Scholar 

  10. Hornig B, Arakawa N, Haussmann D, Drexler H. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998;98:2842-2848.

    PubMed  Google Scholar 

  11. Benjamin N, Cockcroft JR, Collier JG, Dollery CT, Ritter JM, Webb DJ. Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. J Physiol 1989;412:543-555.

    PubMed  Google Scholar 

  12. Haefeli WE, Linder L, Lüscher TF. Quinaprilat induces arterial vasodilation mediated by nitric oxide in humans. Hypertension 1997;30:912-917.

    PubMed  Google Scholar 

  13. Houben AJHM, Schaper NC, de Haan CHA, et al. Local 24-h hyperglycemia does not affect endothelium-dependent or independent vasoreactivity in humans. Am J Physiol 1996;270 (Heart Circ Physiol 39):H2014-H2020.

    PubMed  Google Scholar 

  14. Nussberger J, Brunner DB, Waeber B, Brunner HR. True versus immunoreactive angiotensin II in human plasma. Hypertension 1985;7(Suppl. I):11-17.

    Google Scholar 

  15. Peters RHM, Golbach AJ, Van Den Bergh FAJTM. Automated determination of angiotensin converting enzyme in serum. Clin Chem 1987;33:1248-1251.

    PubMed  Google Scholar 

  16. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 1995;25:918-923.

    PubMed  Google Scholar 

  17. Houben AJHM, Slaaf DW, Huvers FC, de Leeuw PW, Nieuwenhuijzen Kruseman AC, Schaper NC. Diurnal variations in total forearm and skin microcirculatory blood flow in man. Scand J Clin Lab Invest 1994;54:161-169.

    PubMed  Google Scholar 

  18. Nakamura M, Funakoshi T, Yoshida H, Arakawa N, Suzuki T, Hiramori K. Endothelium-dependent vasodilation is augmented by angiotensin converting enzyme inhibitors in healthy volunteers. J Cardiovasc Pharmacol 1992;20:949-954.

    PubMed  Google Scholar 

  19. Olson SC, Horvath AM, Michniewicz BM, Sedman AJ, Colburn WA. The clinical pharmacokinetics of quinapril. Angiology 1989;40:351-359.

    PubMed  Google Scholar 

  20. Lyons D, Webster J, Benjamin N. Effect of enalapril and quinapril on forearm vascular ACE in man. Eur J Clin Pharmacol 1997;51:373-378.

    PubMed  Google Scholar 

  21. Horning B, Kohler C, Drexler H. Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans. Circulation 1997;95:1115-1118.

    PubMed  Google Scholar 

  22. Hecker M, Porsti I, Bara AT, Busse R. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: Interaction at the receptor level. Br J Pharmacol 1994;111:238-244.

    PubMed  Google Scholar 

  23. Anderson TJ, Elstein E, Haber H, Charbonneau F. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANNF study). J Am Coll Cardiol 2000;35:60-66.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University Hospital Maastricht, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands

    A.J.H.M. Houben

  2. Department of Internal Medicine, University Hospital Maastricht, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands

    A.A. Kroon, C.H.A. de Haan, M.J.M.J. Fuss-Lejeune & P.W. de Leeuw

Authors
  1. A.J.H.M. Houben
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A.A. Kroon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C.H.A. de Haan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M.J.M.J. Fuss-Lejeune
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P.W. de Leeuw
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Houben, A., Kroon, A., de Haan, C. et al. Quinaprilat-Induced Vasodilatation in Forearm Vasculature of Patients with Essential Hypertension: Comparison with Enalaprilat. Cardiovasc Drugs Ther 14, 657–663 (2000). https://doi.org/10.1023/A:1007875100562

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007875100562

Search

Navigation